Citations

Citations to this article as recorded by  

• Evaluation of salivary calprotectin as a marker for screening periodontitis using a latex agglutination turbidimetric immunoassay system: a cross-sectional study
  Jun-ichi Kido, Rie Kido, Sachiko Ando, Atsuko Shinozaki, Mika Bando, Yuji Inagaki, Yasuhiro Seki, Yoshiyuki Ohiro, Hiromichi Yumoto
  BMC Oral Health.2026;[Epub]     CrossRef
• Advancements in the exploration and application of turbidimetric assays for biochemical analysis
  Jikai Wang, Ziyi Mo, Haitao Xie, Weiguo Wang, Suisui He, Jun Wang
  TrAC Trends in Analytical Chemistry.2025; 191: 118333.     CrossRef
• Systematic scoping review: Use of the faecal immunochemical test residual buffer to enhance colorectal cancer screening
  Timothy McAuliffe, Joseph C. Anderson, Robin J. Larson, Douglas J. Robertson
  Alimentary Pharmacology & Therapeutics.2024; 59(9): 1033.     CrossRef
• Evaluation of a faecal calprotectin method using the OC-SENSOR PLEDIA
  Shane O’Driscoll, Carolyn Piggott, Sally C. Benton
  Clinical Chemistry and Laboratory Medicine (CCLM).2022; 60(6): 901.     CrossRef
• International consensus on methodological issues in standardization of fecal calprotectin measurement in inflammatory bowel diseases
  Ferdinando D'Amico, David T. Rubin, Paulo Gustavo Kotze, Fernando Magro, Britta Siegmund, Taku Kobayashi, Pablo A. Olivera, Peter Bossuyt, Lieven Pouillon, Edouard Louis, Eugeni Domènech, Subrata Ghosh, Silvio Danese, Laurent Peyrin‐Biroulet
  United European Gastroenterology Journal.2021; 9(4): 451.     CrossRef
• Faecal Calprotectin in Assessment of Mucosal Healing in Adults with Inflammatory Bowel Disease: A Meta-Analysis
  Mariusz A. Bromke, Katarzyna Neubauer, Radosław Kempiński, Małgorzata Krzystek-Korpacka
  Journal of Clinical Medicine.2021; 10(10): 2203.     CrossRef
• Leucine-rich alpha-2 glycoprotein as a marker of mucosal healing in inflammatory bowel disease
  Eriko Yasutomi, Toshihiro Inokuchi, Sakiko Hiraoka, Kensuke Takei, Shoko Igawa, Shumpei Yamamoto, Masayasu Ohmori, Shohei Oka, Yasushi Yamasaki, Hideaki Kinugasa, Masahiro Takahara, Keita Harada, Masaki Furukawa, Kouichi Itoshima, Ken Okada, Fumio Otsuka,
  Scientific Reports.2021;[Epub]     CrossRef
• Optimal Cutoff Level of Fecal Calprotectin for Detecting Small Bowel Inflammation in Crohn's Disease
  Eun Soo Kim
  Gut and Liver.2021; 15(5): 637.     CrossRef
• Fecal calprotectin predicts complete mucosal healing in patients with ulcerative colitis: Systematic review and meta‑analysis
  Zhongsheng Cao, Chenglong Ye, Lunan Li, Xiaoge Geng, Wensheng Pan, Jiyong Jing
  World Academy of Sciences Journal.2021;[Epub]     CrossRef
• Biochemical Biomarkers of Mucosal Healing for Inflammatory Bowel Disease in Adults
  Małgorzata Krzystek-Korpacka, Radosław Kempiński, Mariusz Bromke, Katarzyna Neubauer
  Diagnostics.2020; 10(6): 367.     CrossRef
• Prostaglandin E-Major Urinary Metabolite Predicts Relapse in Patients With Ulcerative Colitis in Clinical Remission
  Natsuki Ishida, Kiichi Sugiura, Takahiro Miyazu, Satoshi Tamura, Satoshi Suzuki, Shinya Tani, Mihoko Yamade, Moriya Iwaizumi, Yasushi Hamaya, Satoshi Osawa, Takahisa Furuta, Ken Sugimoto
  Clinical and Translational Gastroenterology.2020; 11(12): e00289.     CrossRef
• Prediction of treatment outcome and relapse in inflammatory bowel disease
  Jun Kato, Takeichi Yoshida, Sakiko Hiraoka
  Expert Review of Clinical Immunology.2019; 15(6): 667.     CrossRef

Citations

Citations to this article as recorded by  

• Histologic features and predicting prognosis in ulcerative colitis patients with mild endoscopic activity
  Seung Yong Shin, Hee Sung Kim, Kisung Kim, Chang Won Choi, Jung Min Moon, Jeong Wook Kim, Hyun Jin Joo, Jeongkuk Seo, Muhyeon Sung, Chang Hwan Choi
  The Korean Journal of Internal Medicine.2024; 39(1): 68.     CrossRef
• Prostaglandin E‐major urinary metabolite diagnoses mucosal healing in patients with ulcerative colitis in remission phase
  Toshiyuki Sakurai, Yoshihiro Akita, Haruna Miyashita, Ryosuke Miyazaki, Yuki Maruyama, Tomoko Saito, Mariko Shimada, Takuji Yamasaki, Seiji Arhihiro, Tomohiro Kato, Tomokazu Matsuura, Masahiro Ikegami, Isao Okayasu, Masayuki Saruta
  Journal of Gastroenterology and Hepatology.2022; 37(5): 847.     CrossRef
• Alternative diagnoses and demographics associated with a raised quantitative faecal immunochemical test in symptomatic patients
  Mark S Johnstone, Gillian Miller, Grace Pang, Paul Burton, Georgios Kourounis, Jack Winter, Emilia Crighton, David Mansouri, Paul Witherspoon, Karen Smith, Stephen T McSorley
  Annals of Clinical Biochemistry: International Journal of Laboratory Medicine.2022; 59(4): 277.     CrossRef
• Correlation of fecal calprotectin and patient-reported outcome measures in patients with ulcerative colitis
  Nagesh Kamat, Sudheer K Vuyyuru, Saurabh Kedia, Pabitra Sahu, Bhaskar Kante, Peeyush Kumar, Mukesh Kumar Ranjan, Mukesh Kumar Singh, Sambuddha Kumar, Vikas Sachdev, Govind Makharia, Vineet Ahuja
  Intestinal Research.2022; 20(2): 269.     CrossRef
• Determining the usefulness of Capsule Scoring of Ulcerative Colitis in predicting relapse of inactive ulcerative colitis
  Mao Matsubayashi, Taku Kobayashi, Shinji Okabayashi, Masaru Nakano, Shintaro Sagami, Ryo Ozaki, Hiroki Kiyohara, Hiromu Morikubo, Kunio Asonuma, Yusuke Miyatani, Shin Maeda, Toshifumi Hibi
  Journal of Gastroenterology and Hepatology.2021; 36(4): 943.     CrossRef
• Biomarkers of Inflammation in Inflammatory Bowel Disease: How Long before Abandoning Single-Marker Approaches?
  Gabriele Dragoni, Tommaso Innocenti, Andrea Galli
  Digestive Diseases.2021; 39(3): 190.     CrossRef
• Biomarkers Predictive of Response to Thiopurine Therapy in Inflammatory Bowel Disease
  Jack S. Cornish, Elisa Wirthgen, Jan Däbritz
  Frontiers in Medicine.2020;[Epub]     CrossRef
• Predictive values of stool-based tests for mucosal healing among Taiwanese patients with ulcerative colitis: a retrospective cohort analysis
  Hsu-Heng Yen, Mei-Wen Chen, Yu-Yao Chang, Hsuan-Yuan Huang, Tsui-Chun Hsu, Yang-Yuan Chen
  PeerJ.2020; 8: e9537.     CrossRef
• What is the appropriate cut-off value of CRP to predict endoscopic remission in patients with ulcerative colitis in clinical remission?
  Jongbeom Shin, Sung Min Kong, Gyeol Seong, Young-Ho Kim
  International Journal of Colorectal Disease.2020; 35(12): 2249.     CrossRef
• Prostaglandin E-Major Urinary Metabolite Predicts Relapse in Patients With Ulcerative Colitis in Clinical Remission
  Natsuki Ishida, Kiichi Sugiura, Takahiro Miyazu, Satoshi Tamura, Satoshi Suzuki, Shinya Tani, Mihoko Yamade, Moriya Iwaizumi, Yasushi Hamaya, Satoshi Osawa, Takahisa Furuta, Ken Sugimoto
  Clinical and Translational Gastroenterology.2020; 11(12): e00289.     CrossRef
• Approaches to Integrating Biomarkers Into Clinical Trials and Care Pathways as Targets for the Treatment of Inflammatory Bowel Diseases
  Parambir S. Dulai, Laurent Peyrin-Biroulet, Silvio Danese, Bruce E. Sands, Axel Dignass, Dan Turner, Gerassimos Mantzaris, Juergen Schölmerich, Jean-Yves Mary, Walter Reinisch, William J. Sandborn
  Gastroenterology.2019; 157(4): 1032.     CrossRef

Accurate evaluation of disease activity is essential for choosing an appropriate treatment and follow-up plan for patients with inflammatory bowel disease (IBD). Endoscopy is required for accurately evaluating disease activity, but the procedures are sometimes invasive and burdensome to patients. Therefore, alternative non-invasive methods for evaluating or predicting disease activity including mucosal status are desirable. Fecal calprotectin (Fcal) is the most widely used fecal marker for IBD, and many articles have described the performance of the marker in predicting disease activity, mucosal healing (MH), treatment efficacy, and risk of relapse. Fecal immunochemical test (FIT) can quantify the concentration of hemoglobin in stool and was originally used for the screening of colorectal cancer. We recently reported that FIT is also a useful biomarker for IBD. A direct comparison between the use of Fcal and FIT showed that both methods predicted MH in ulcerative colitis equally well. However, in the case of Crohn's disease, FIT was less sensitive to lesions in the small intestine, compared to Fcal. FIT holds several advantages over Fcal in regards to user-friendliness, including a lower cost, easy and clean handling, and the ability to make rapid measurements by using an automated measurement system. However, there is insufficient data to support the application of FIT in IBD. Further studies into the use of FIT for evaluating the inflammatory status of IBD are warranted.

Citations

Citations to this article as recorded by  

• Delivery of Encapsulated Intelligent Engineered Probiotic for Inflammatory Bowel Disease Therapy
  Zhen‐Ping Zou, Zhihao Cai, Xiao‐Peng Zhang, Donghui Zhang, Chu‐Ying Xu, Ying Zhou, Runhui Liu, Bang‐Ce Ye
  Advanced Healthcare Materials.2025;[Epub]     CrossRef
• The usefulness of serum leucine-rich alpha-2 glycoprotein as a novel biomarker in monitoring inflammatory bowel disease: a systematic review and meta-analysis
  Fatemeh Ojaghi Shirmard, Seyed Morteza Pourfaraji, Behrad Saeedian, Tannaz Bagheri, Abdulrahman Ismaiel, Satohiro Matsumoto, Nastaran Babajani
  European Journal of Gastroenterology & Hepatology.2025; 37(8): 891.     CrossRef
• The Relationship Between Disease Activity and Fecal Calprotectin and Fecal Occult Blood in Inflammatory Bowel Disease: The Role of Nutritional Status
  Ali Bilgen, Hale Akpınar
  Nutrients.2025; 17(21): 3379.     CrossRef
• The synergy of dual faecal immunochemical and faecal calprotectin testing for accurate assessment of endoscopic and histological activity in inflammatory bowel disease
  Anuj Bohra, Nicholas Batt, Krishneel Dutt, Diana Lewis, Jonathan P. Segal, Olga Newiadomski, Abhinav Vasudevan, Daniel R. Van Langenberg
  Therapeutic Advances in Gastroenterology.2024;[Epub]     CrossRef
• Biomarkers in inflammatory bowel disease: a practical guide
  Jennie Clough, Michael Colwill, Andrew Poullis, Richard Pollok, Kamal Patel, Sailish Honap
  Therapeutic Advances in Gastroenterology.2024;[Epub]     CrossRef
• Multimodal Ultrasound Technology Combined with Fecal Calprotectin Assessment in Clinical Studies of Inflammatory Bowel Disease
  泊辛 陈
  Advances in Clinical Medicine.2024; 14(07): 1110.     CrossRef
• Unraveling the intricacies of neutrophil extracellular traps in inflammatory bowel disease: Pathways, biomarkers, and promising therapies
  Yilin Wu, Jun Shen
  Cytokine & Growth Factor Reviews.2024; 80: 156.     CrossRef
• Positive Results from the Fecal Immunochemical Test Can Be Related to Dementia: A Nationwide Population-Based Study in South Korea
  Yu Kyung Jun, Seung Woo Lee, Kwang Woo Kim, Jung Min Moon, Seong-Joon Koh, Hyun Jung Lee, Joo Sung Kim, Kyungdo Han, Jong Pil Im
  Journal of Alzheimer's Disease.2023; 91(4): 1515.     CrossRef
• Fecal immunochemical test for haemoglobin versus fecal calprotectin to monitoring endoscopic activity in inflammatory bowel disease
  Patricia Latorre Añó, Jorge Torrente Sánchez, Amparo Almudena Pérez Ibañez, Jose María Tenias Burillo, Nadia Paloma Moreno Sánchez, Antonio López-Serrano, Eduardo Moreno Osset, Julián Murado Pardo, José María Paredes
  Revista Española de Enfermedades Digestivas.2023;[Epub]     CrossRef
• Tumorigenesis in Inflammatory Bowel Disease: Microbiota-Environment Interconnections
  Irene Mignini, Maria Elena Ainora, Silvino Di Francesco, Linda Galasso, Antonio Gasbarrini, Maria Assunta Zocco
  Cancers.2023; 15(12): 3200.     CrossRef
• Propensity score analysis the clinical characteristics of active distal and extensive ulcerative colitis: a retrospective study
  Changchang Ge, Zhaofeng Shen, Yi Lu, Xiaojuan Liu, Yiheng Tong, Mengyuan Zhang, Yijing Liu, Hong Shen, Lei Zhu
  Frontiers in Physiology.2023;[Epub]     CrossRef
• A unicentric cross-sectional observational study on chronic intestinal inflammation in total colonic aganglionosis: beware of an underestimated condition
  M Erculiani, F Poluzzi, G Mottadelli, E Felici, Novi ML, M Caraccia, A Grandi, S Casella, L Giacometti, G Montobbio, I Ceccherini, E Di Marco, C Bonaretti, R Biassoni, M Squillario, A Pietrantoni, V Villanacci, A Pini Prato
  Orphanet Journal of Rare Diseases.2023;[Epub]     CrossRef
• Fecal miR‐223 is a noninvasive biomarker for estimating Crohn's disease activity
  Juanjuan Zhang, Zhen Guo, Zhiming Wang, Weiming Zhu, Qiurong Li
  Immunity, Inflammation and Disease.2023;[Epub]     CrossRef
• Monitoring of intestinal inflammation and prediction of recurrence in ulcerative colitis
  Changchang Ge, Yi Lu, Hong Shen, Lei Zhu
  Scandinavian Journal of Gastroenterology.2022; 57(5): 513.     CrossRef
• Efficacy of Fecal Calprotectin Combined With Stool Hemoglobin in Differentiating Bacterial Origin in Acute Gastroenteritis
  Hyun Jin Kim
  Pediatric Emergency Care.2022; 38(2): e670.     CrossRef
• Colorectal Cancer Screening in Inflammatory Bowel Diseases—Can Characterization of GI Microbiome Signatures Enhance Neoplasia Detection?
  Molly Pratt, Jessica D. Forbes, Natalie C. Knox, Gary Van Domselaar, Charles N. Bernstein
  Gastroenterology.2022; 162(5): 1409.     CrossRef
• Occult Blood in Feces Is Associated with Increased Risk of Psoriasis
  Hyun Jung Lee, Kyungdo Han, Hosim Soh, Seong-Joon Koh, Jong Pil Im, Joo Sung Kim, Hyo Eun Park, Miri Kim
  Dermatology.2022; 238(3): 571.     CrossRef
• Analytical evaluation of four faecal immunochemistry tests for haemoglobin
  Carolyn Piggott, Magdalen R. R. Carroll, Cerin John, Shane O’Driscoll, Sally C. Benton
  Clinical Chemistry and Laboratory Medicine (CCLM).2021; 59(1): 173.     CrossRef
• Surrogate markers of mucosal healing in inflammatory bowel disease: A systematic review
  Monica State, Lucian Negreanu, Theodor Voiosu, Andrei Voiosu, Paul Balanescu, Radu Bogdan Mateescu
  World Journal of Gastroenterology.2021; 27(16): 1828.     CrossRef
• Cost effectiveness of using Faecal Immunochemical Testing (FIT) as an initial diagnostic investigation for patients with lower gastrointestinal symptoms suggestive of malignancy
  CC Kearsey, C Graham, HS Lobb, J Chacko, R Weatherburn, PS Rooney
  BMC Family Practice.2021;[Epub]     CrossRef
• Lymphocyte-to-Monocyte Ratio as a Marker for Endoscopic Activity in Ulcerative Colitis
  Natsuki Ishida, Satoru Takahashi, Yusuke Asai, Takahiro Miyazu, Satoshi Tamura, Shinya Tani, Mihoko Yamade, Moriya Iwaizumi, Yasushi Hamaya, Satoshi Osawa, Takahisa Furuta, Ken Sugimoto
  Immuno.2021; 1(4): 360.     CrossRef
• Optimal Range of Fecal Calprotectin for Predicting Mucosal Healing in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis
  Bing-Jie Xiang, Min Jiang, Ming-Jun Sun, Cong Dai
  Visceral Medicine.2021; 37(5): 338.     CrossRef
• Role of Biomarkers in the Diagnosis and Treatment of Inflammatory Bowel Disease
  Kohei Wagatsuma, Yoshihiro Yokoyama, Hiroshi Nakase
  Life.2021; 11(12): 1375.     CrossRef
• Fecal calprotectin predicts complete mucosal healing in patients with ulcerative colitis: Systematic review and meta‑analysis
  Zhongsheng Cao, Chenglong Ye, Lunan Li, Xiaoge Geng, Wensheng Pan, Jiyong Jing
  World Academy of Sciences Journal.2021;[Epub]     CrossRef
• Fecal calprotectin is more accurate than fecal immunochemical test for predicting mucosal healing in quiescent ulcerative colitis: a prospective multicenter study
  Eun Soo Kim, Hyun Seok Lee, Sung Kook Kim, Eun Young Kim, Byung Ik Jang, Kyeong Ok Kim, Chang Heon Yang, Yoo Jin Lee
  Scandinavian Journal of Gastroenterology.2020; 55(2): 163.     CrossRef
• Biomarkers Predictive of Response to Thiopurine Therapy in Inflammatory Bowel Disease
  Jack S. Cornish, Elisa Wirthgen, Jan Däbritz
  Frontiers in Medicine.2020;[Epub]     CrossRef
• Effect of ulcerative colitis duration on the usefulness of immunochemical fecal occult blood test result as a disease activity biomarker
  Natsuki Ishida, Takahiro Miyazu, Tomoharu Matsuura, Ryosuke Takano, Satoshi Tamura, Takuma Kagami, Shinya Tani, Mihoko Yamade, Yasushi Hamaya, Moriya Iwaizumi, Satoshi Osawa, Takahisa Furuta, Ken Sugimoto
  International Journal of Colorectal Disease.2020; 35(9): 1729.     CrossRef
• Fecal MicroRNAs as Potential Biomarkers for Screening and Diagnosis of Intestinal Diseases
  Humaira Rashid, Biplob Hossain, Towfida Siddiqua, Mamun Kabir, Zannatun Noor, Mamun Ahmed, Rashidul Haque
  Frontiers in Molecular Biosciences.2020;[Epub]     CrossRef
• The association between fecal hemoglobin concentration and oral potentially malignant disorders
  Amy Ming‐Fang Yen, Sen‐Te Wang, Sheng‐Wei Feng, Che‐Tong Lin, Sam Li‐Sheng Chen
  Oral Diseases.2019; 25(1): 108.     CrossRef
• Cell-Free DNA as a Diagnostic Blood-Based Biomarker for Colorectal Cancer: A Systematic Review
  Joel Petit, Georgia Carroll, Tiffany Gould, Peter Pockney, Matthew Dun, Rodney J. Scott
  Journal of Surgical Research.2019; 236: 184.     CrossRef
• Faecal calprotectin in inflammatory bowel diseases: a review focused on meta-analyses and routine usage limitations
  Emilio J. Laserna-Mendieta, Alfredo J. Lucendo
  Clinical Chemistry and Laboratory Medicine (CCLM).2019; 57(9): 1295.     CrossRef
• Systematic Review with Meta-Analysis: Fecal Calprotectin as a Surrogate Marker for Predicting Relapse in Adults with Ulcerative Colitis
  Jiajia Li, Xiaojing Zhao, Xueting Li, Meijiao Lu, Hongjie Zhang
  Mediators of Inflammation.2019; 2019: 1.     CrossRef
• Predictors of mucosal healing during induction therapy in patients with acute moderate‐to‐severe ulcerative colitis
  Maiko Motobayashi, Katsuyoshi Matsuoka, Kento Takenaka, Toshimitsu Fujii, Masakazu Nagahori, Kazuo Ohtsuka, Fumihiko Iwamoto, Kiichiro Tsuchiya, Mariko Negi, Yoshinobu Eishi, Mamoru Watanabe
  Journal of Gastroenterology and Hepatology.2019; 34(6): 1004.     CrossRef
• Clinical implications of fecal calprotectin and fecal immunochemical test on mucosal status in patients with ulcerative colitis
  Dae Gon Ryu, Hyung Wook Kim, Su Bum Park, Dae Hwan Kang, Cheol Woong Choi, Su Jin Kim, Hyeong Seok Nam
  Medicine.2019; 98(36): e17080.     CrossRef
• Fecal immunochemical test for predicting mucosal healing in ulcerative colitis patients: A systematic review and meta‐analysis
  Cong Dai, Min Jiang, Ming‐Jun Sun, Qin Cao
  Journal of Gastroenterology and Hepatology.2018; 33(5): 990.     CrossRef
• Monitoring Disease Activity: How and When?
  Kang-Moon Lee
  The Korean Journal of Gastroenterology.2018; 71(2): 69.     CrossRef
• An assessment of the effect of haemoglobin variants on detection by faecal immunochemical tests
  Magdalen RR Carroll, Cerin John, Debbie Mantio, Natasha K Djedovic, Sally C Benton
  Annals of Clinical Biochemistry: International Journal of Laboratory Medicine.2018; 55(6): 706.     CrossRef
• Fecal Immunochemical Test and Fecal Calprotectin Results Show Different Profiles in Disease Monitoring for Ulcerative Colitis
  Sakiko Hiraoka, Toshihiro Inokuchi, Asuka Nakarai, Shiho Takashima, Daisuke Takei, Yuusaku Sugihara, Masahiro Takahara, Keita Harada, Hiroyuki Okada, Jun Kato
  Gut and Liver.2018; 12(2): 142.     CrossRef
• Simultaneous Measurements of Faecal Calprotectin and the Faecal Immunochemical Test in Quiescent Ulcerative Colitis Patients Can Stratify Risk of Relapse
  Asuka Nakarai, Sakiko Hiraoka, Sakuma Takahashi, Tomoki Inaba, Reiji Higashi, Motowo Mizuno, Shiho Takashima, Toshihiro Inokuchi, Yuusaku Sugihara, Masahiro Takahara, Keita Harada, Jun Kato, Hiroyuki Okada
  Journal of Crohn's and Colitis.2018; 12(1): 71.     CrossRef
• Accuracy of Faecal Immunochemical Test to Predict Endoscopic and Histological Healing in Ulcerative Colitis: A Prospective Study Based on Validated Histological Scores
  Hai Yun Shi, Francis K. L Chan, Anthony W. H Chan, Akira Higashimori, Moe Kyaw, Jessica Y. L Ching, Arthur K. C Luk, Sunny H Wong, Justin C. Y Wu, Joseph J. Y Sung, Siew C Ng
  Journal of Crohn's and Colitis.2017; 11(9): 1071.     CrossRef
• Serum Adipocytokine Levels as Surrogate Markers for Disease Activity of Crohn’s Disease
  Su Hwan Kim, Seung Hyeon Jang, Ji Won Kim, Byeong Gwan Kim, Kook Lae Lee, You Sun Kim, Dong Soo Han, Joo Sung Kim
  The American Journal of the Medical Sciences.2017; 353(5): 439.     CrossRef
• Fecal calprotectin as a non‐invasive biomarker for intestinal involvement of Behçet's disease
  Duk Hwan Kim, Yehyun Park, Bun Kim, Seung Won Kim, Soo Jung Park, Sung Pil Hong, Tae Il Kim, Won Ho Kim, Jae Hee Cheon
  Journal of Gastroenterology and Hepatology.2017; 32(3): 595.     CrossRef
• Noninvasive Fecal Immunochemical Testing and Fecal Calprotectin Predict Mucosal Healing in Inflammatory Bowel Disease
  Christopher Ma, Rowan Lumb, Emily V. Walker, Rae R. Foshaug, ThucNhi T. Dang, Sanam Verma, Vivian W. Huang, Karen I. Kroeker, Karen Wong, Levinus A. Dieleman, Richard N. Fedorak, Brendan P. Halloran
  Inflammatory Bowel Diseases.2017; 23(9): 1643.     CrossRef
• Detection of calprotectin in inflammatory bowel disease: Fecal and serum levels and immunohistochemical localization
  Shuhei Fukunaga, Kotaro Kuwaki, Keiichi Mitsuyama, Hidetoshi Takedatsu, Shinichiro Yoshioka, Hiroshi Yamasaki, Ryosuke Yamauchi, Atsushi Mori, Tatsuyuki Kakuma, Osamu Tsuruta, Takuji Torimura
  International Journal of Molecular Medicine.2017;[Epub]     CrossRef
• Fecal biomarkers in inflammatory bowel disease: how, when and why?
  Paula Ministro, Diana Martins
  Expert Review of Gastroenterology & Hepatology.2017; 11(4): 317.     CrossRef
• Assessment of disease activity by fecal immunochemical test in ulcerative colitis
  Dae Gon Ryu, Hyung Wook Kim, Su Bum Park, Dae Hwan Kang, Cheol Woong Choi, Su Jin Kim, Hyeong Seok Nam
  World Journal of Gastroenterology.2016; 22(48): 10617.     CrossRef
• Does Gastric Surgery (Such as Bariatric Surgery) Impact the Risk of Intestinal Inflammation?
  Daniel Gero, Christian A. Gutschow, Marco Bueter
  Inflammatory Intestinal Diseases.2016; 1(3): 129.     CrossRef